Authors:
Jernigan, JA
Stephens, DS
Ashford, DA
Omenaca, C
Topiel, MS
Galbraith, M
Tapper, M
Fisk, TL
Zaki, S
Popovic, T
Meyer, RF
Quinn, CP
Harper, SA
Fridkin, SK
Sejvar, JJ
Shepard, CW
McConnell, M
Guarner, J
Shieh, WJ
Malecki, JM
Gerberding, JL
Hughes, JM
Perkins, BA
Citation: Ja. Jernigan et al., Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States, EM INFECT D, 7(6), 2001, pp. 933-944
Citation: Sk. Fridkin, Vancomycin-intermediate and -resistant Staphylococcus aureus: What the infectious disease specialist needs to know, CLIN INF D, 32(1), 2001, pp. 108-115
Authors:
Fridkin, SK
Edwards, JR
Courval, JM
Hill, H
Tenover, FC
Lawton, R
Gaynes, RP
McGowan, JE
Citation: Sk. Fridkin et al., The effect of vancomycin and third-generation cephalosporins on prevalenceof vancomycin-resistant enterococci in 126 US adult intensive care units, ANN INT MED, 135(3), 2001, pp. 175-183
Authors:
Lawton, RM
Fridkin, SK
Gaynes, RP
McGowan, JE
Citation: Rm. Lawton et al., Practices to improve antimicrobial use at 47 US hospitals: The status of the 1997 SHEA/IDSA position paper recommendations, INFECT CONT, 21(4), 2000, pp. 256-259
Authors:
Robert, J
Fridkin, SK
Blumberg, HM
Anderson, B
White, N
Ray, SM
Chan, J
Jarvis, WR
Citation: J. Robert et al., The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit, INFECT CONT, 21(1), 2000, pp. 12-17
Authors:
Steward, CD
Wallace, D
Hubert, SK
Lawton, R
Fridkin, SK
Gaynes, RP
McGowan, JE
Tenover, FC
Citation: Cd. Steward et al., Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories, DIAG MICR I, 38(1), 2000, pp. 59-67
Authors:
Fridkin, SK
Steward, CD
Edwards, JR
Pryor, ER
McGowan, JE
Archibald, LK
Gaynes, RP
Tenover, FC
Citation: Sk. Fridkin et al., Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2, CLIN INF D, 29(2), 1999, pp. 245-252
Authors:
Fridkin, SK
Edwards, JR
Pichette, SC
Pryor, ER
McGowan, JE
Tenover, FC
Culver, DH
Gaynes, RP
Citation: Sk. Fridkin et al., Determinants of vancomycin use in adult intensive care units in 41 United States hospitals, CLIN INF D, 28(5), 1999, pp. 1119-1125
Authors:
Lawton, RM
Fridkin, SK
Steward, CD
Edwards, JR
Pryor, ER
McGowan, JE
Archibald, LK
Gaynes, RP
Tenover, FC
Pichette, SC
Mohammed, J
Felicione, E
Hubert, S
Citation: Rm. Lawton et al., Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, Data Summary from January 1996 through December 1997, AM J INFECT, 27(3), 1999, pp. 279-284
Authors:
Hubert, SK
Mohammed, JM
Fridkin, SK
Gaynes, RP
McGowan, JE
Tenover, FC
Citation: Sk. Hubert et al., Glycopeptide-intermediate Staphylococcus aureus: Evaluation of a novel screening method and results of a survey of selected US hospitals, J CLIN MICR, 37(11), 1999, pp. 3590-3593
Authors:
Jarvis, WR
Gaynes, RP
Horan, TC
Alonso-Echanove, J
Emori, TG
Fridkin, SK
Lawton, RM
Richards, MJ
Wright, GC
Culver, DH
Abshire, JP
Edwards, JR
Henderson, TS
Peavy, GE
Tolson, JS
Wages, JT
Citation: Wr. Jarvis et al., National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986 April 1998, issued June 1998, AM J INFECT, 26(5), 1998, pp. 522-533